Featured Research

from universities, journals, and other organizations

Enzyme Inhibitor Reduces Cardiac Cell Death In Heart Attack

Date:
September 10, 1999
Source:
Northwestern University
Summary:
Caspases are a remarkable and intricately regulated network of enzymes that can trigger cell suicide in animals from yeast and worms to humans. Now, experiments conducted by researchers at Northwestern University Medical School have found that the cardiac cell death that occurs during heart "attack" is caused by activation of several caspases.

CHICAGO --- Caspases are a remarkable and intricately regulated network of enzymes that can trigger cell suicide in animals from yeast and worms to humans. Caspases are known to mediate programmed cell death in a number of diseases, including ischemic brain injury, or stroke.

Related Articles


Now, experiments conducted by researchers at Northwestern University Medical School have found that the cardiac cell death that occurs during heart "attack" is caused by activation of several caspases. In addition, they showed in a laboratory model that administering an experimental caspase inhibitor known as YVAD-cmk not only blocks this biochemical cascade but also protects heart tissue, dramatically reducing the amount of myocardial death by over 30 percent.

Vincent L. Cryns, M.D., and colleagues in the Feinberg Cardiovascular Research Institute at Northwestern published the results of a study on programmed cell death and heart attack in the September issue of the Journal of Molecular and Cell Cardiology.

"We believe that caspases may be important therapeutic targets in heart attack," said Cryns, an assistant professor at the Medical School.

Caspases are the universal effectors of programmed cell death, or apoptosis. In response to apoptotic stimuli, such as DNA damage, growth factor deprivation and stress, caspases chop up certain cell proteins and also sequentially activate other caspases down the line to follow suit, thus transmitting and amplifying death signals to cells.

The Northwestern study is the first to find that multiple caspases are activated during myocardial ischemia -- reduced oxygen flow to the heart that can lead to a heart attack.

Apoptosis is a genetically regulated response that plays an important role in development, tissue maintenance and human disease. On the one hand, programmed cell death removes cells that are no longer needed during embryonic development, e.g., the formation of individual fingers and toes from budding limbs. On the other, it also is the means by which the body eliminates damaged or diseased cells.

However, uncontrolled apoptosis causes many human illnesses, including heart disease, cancer, neurodegenerative diseases and autoimmune disorders.

Cryns' research is aimed at understanding and describing the apoptotic pathways -- the crucial steps that activate the caspase cascade and how to block them to prevent cell death associated with heart attack, stroke or other debilitating diseases.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Enzyme Inhibitor Reduces Cardiac Cell Death In Heart Attack." ScienceDaily. ScienceDaily, 10 September 1999. <www.sciencedaily.com/releases/1999/09/990910080508.htm>.
Northwestern University. (1999, September 10). Enzyme Inhibitor Reduces Cardiac Cell Death In Heart Attack. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/1999/09/990910080508.htm
Northwestern University. "Enzyme Inhibitor Reduces Cardiac Cell Death In Heart Attack." ScienceDaily. www.sciencedaily.com/releases/1999/09/990910080508.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins